REFERENCES:
  1. Rim M. Harfouch, Samer Alshaikh, Mohammad Alshimaly, Amany Assaad, Jehan Ahmad, Haya Zoughaibi, Maher Hammadi, Yahya Elshimali. Therapeutic approaches for COVID 19: Challenges and successes. Ann Clin Anal Med 2020; DOI: 10.4328/ACAM.20270
  2. World Health Organization (WHO). WHO Statement Regarding Cluster of Pneumonia Cases in Wuhan, China. Beijing: WHO; 9 Jan 2020. [Accessed 11 Jan 2020]. https://www.who.int/china/ news/detail/09-01-2020-who-statement-regarding-cluster-of pneumonia-cases-in-wuhan-china
  3. Harfouch RM, Moualla YM, Shahoud SM, Belal LA, Mohammad BS, Mustafa NM, Souliman OA, Elshemali YI (2021). Epidemiology of COVID-19 in the most pandemic Countries: A review article. Acad . J. Biotechnol. 9(1): 021-027
  4. Li W, Shi Z, Yu M, Ren W, Smith C, Epstein JH, et al. Bats are natural reservoirs of SARS-like coronaviruses. Science. 2005;310(5748):676–9.
  5. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet 395 (10223) (2020) 497–506, https://doi.org/10.1016/S0140-6736(20)30183-5.
  6. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020. https://doi.org/10. 1056/NEJMoa2002032.
  7. Liu J, Liao X, Qian S et al. Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen, China, 2020. Emerg Infect Dis 2020 doi.org/10.3201/eid2606.200239
  8. World Health Organization. ”Coronavirus disease 2019 (COVID-19): Situation Report, 66.” (2020)
  9. WHO Infection Prevention and Control Guidance for COVID-19 available at https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/infection-prevention-and-control.
  10. Abdi. M. Coronavirus disease 2019 (COVID-19) outbreak in Iran; actions and problems. Infection Control & Hospital Epidemiology. (2020)
  11. WHO. Coronavirus disease (COVID-2019) situation reports : Situation report - 31 . 20-2-2020: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200220-sitrep-31-covid-19.pdf?sfvrsn=dfd11d24_2
  12. WHO. Coronavirus disease (COVID-2019) situation reports : Situation report - 38 . 27-2-2020: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200227-sitrep-38-covid-19.pdf?sfvrsn=2db7a09b_4
  13. WHO. Coronavirus disease (COVID-2019) situation reports : Situation report - 65 . 25-3-2020,https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200325-sitrep-65-covid-19.pdf?sfvrsn=2b74edd8_2
  14. Grasselli G, Pesenti A, Cecconi M. Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response [published online ahead of print, 2020 Mar 13]. JAMA. 2020;10.1001/jama.2020.4031. doi:10.1001/jama.2020.4031
  15. Day, Michael. ”Covid-19: Italy confirms 11 deaths as cases spread from north.” (2020)
  16. Porcheddu, Rossella, et al. ”Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China.” The Journal of Infection in Developing Countries 14.02 (2020): 125-128.
  17. Paterlini, Marta. ”On the front lines of coronavirus: the Italian response to covid-19.” BMJ 368 (2020).‏
  18. Remuzzi, Andrea, and Giuseppe Remuzzi. ”COVID-19 and Italy: what next?.” The Lancet (2020).‏
  19. World Health Organization. ”Coronavirus disease 2019 (‎ COVID-19)‎: situation report, 66.” (2020)
  20. Sibylle Bernard Stoecklin, 1 Patrick Rolland, 2 Yassoungo Silue, 3 Alexandra Mailles, Christine Campese,  Anne Simondon, et al. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020.Europe’s journal on infectious disease epidemiology, prevention and control since 1996.Euro Surveill. 2020 Feb 13; 25(6): 2000094.doi: 10.2807/1560-7917.ES.2020.25.6.2000094
  21. World Health Organization. WHO statement on novel coronavirus in thailand. 2020. https://www.who. int/news-room/detail/13-01-2020-who-statement-on-novel-coronavirus-in-thailand.
  22. Santé Publique France. Point épidémiologique -situation au 5 mars 2020 -15h. 2020. https://www. santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/infection-acoronavirus/documents/bulletin-national/covid-19-point-epidemiologique-du-5-mars-2020.
  23. Julie Figoni Fatima Aït El Belghiti Didier Che Patrick Rolland. COVID-19 Point épidémiologique - Situation au 7 mars 2020. Santé Public France.
  24. Santé Publique France. Point épidémiologique -situation au 10 mars 2020 à minuit. 2020. https: //www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/infectiona-coronavirus/documents/bulletin-national/covid-19-point-epidemiologique-du-10-mars-2020.
  25. World Health Organization. Infection prevention and control during health care when COVID-19 is suspected https://www.who.int/publications-detail/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125
  26. Clément Massonnaud1,2*, Jonathan Roux1, Pascal Crépey1„. COVID-19: Forecasting short term hospital needs in France.
  27. Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., … & Diaz, G. (2020). First case of 2019 novel coronavirus in the United States. New England Journal of Medicine.
  28. Patel, A., & Jernigan, D. B. (2020). Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak—United States, December 31, 2019–February 4, 2020. Morbidity and Mortality Weekly Report, 69(5), 140.
  29. Burke, R. M. (2020). Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19—United States, January–February 2020. MMWR. Morbidity and Mortality Weekly Report, 69.
  30. Chih-Cheng Lai , Cheng-Yi Wang , Ya-Hui Wang , Shun-Chung Hsueh , Wen-Chien Ko, Po-Ren Hsueh , Global epidemiology of coronavirus disease 2019: disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status, International Journal of Antimicrobial Agents (2020)
  31. https://www.who.int/docs/default-source/coronaviruse/situation-reports/ 20200314-sitrep-54-covid-19.pdf?sfvrsn=dcd46351_8
  32. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200317-sitrep-57-covid-19.pdf?sfvrsn=a26922f2_4
  33. https://www.cdc.gov/covid-data-tracker/#cases
  34. Wang XW, Li JS, Zhen B, Kong QX, Song N, Xiao WJ et al. Study on the resistance of severe acute respiratory syndrome-associated coronavirus. J Virol Methods. 2005;126:171−7. doi:10.1016/j.jviromet.2005.02.005
  35. Guidelines for drinking-water quality, fourth edition, incorporating the first addendum. Geneva: World Health Organization; 2017 (http://apps.who.int/iris/bitstream/10665/254637/1/9789241549950eng.pdf, accessed 3 March 2020).
  36. Casanova L, Rutalal WA, Weber DJ, Sobsey MD. Survival of surrogate coronaviruses in water. Water Res. 2009;43(7):1893–8. doi:10.1016/j.watres.2009.02.002.
  37. Yeo, Charleen, Sanghvi Kaushal, and Danson Yeo. ”Enteric involvement of coronaviruses: is faecal–oral transmission of SARS-CoV-2 possible?.” The Lancet Gastroenterology & Hepatology 5.4 (2020): 335-337.‏
  38. Gu, Jinyang, Bing Han, and Jian Wang. ”COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission.” Gastroenterology (2020).‏
  39. Wei Luo, MaimunaS.Majumder, Diambo Liu, Canelle Poirier, Kenneth D Mandl, Marc Lipsitch,Mauricio Santillana.The role of absolute humidity on transmission rates of the COVID-19outbreak. http://nrs.harvard.edu/urn-3:HUL.InstRepos:42639515
  40. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.The new england journal of medicine. DOI: 10.1056/NEJMc2004973
  41. Coronavirus survives on surgical masks for up to SEVEN days but WHO reveals there is only a ’low risk’ of catching the virus from newspapers and other delivered goods.By Joe Pinkstone For Mailonline17:23 BST 27 Mar 2020 , updated 17:48 BST 27 Mar 2020. https://www.dailymail.co.uk/sciencetech/article-8160885/Coronavirus-survives-surgical-masks-SEVEN-days.html
  42. Kampf G, Todt D, Pfaender S, Steinmann E, Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents, Journal of Hospital Infection, https://doi.org/10.1016/j.jhin.2020.01.022.